D
Dalriada is a small molecule drug discovery company supporting global innovators through its TURN-KEY™ model, where R&D is perfectly aligned with business and IP. With all R&D operations in Mississauga, Canada, we build focused expert teams in MedChem, Biology and ADME to allow for the most rapid project advancements and value building. Continuing to innovate alongside start-ups and billion-dollar companies…
Investor insights
Funding rounds participated in
$25K sweet spot round size
Investor type
Privately Held
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Date founded
2017
Funding rounds raised
Total raised
$25K
from investors over 1 rounds
D
Dalriada Drug Discovery raised $25K on December 13, 2020